Cargando…
COVID-19-related prescribing challenge in intellectual disability
BACKGROUND: The COVID-19 pandemic and associated restrictions are expected to affect the mental health of the population, especially people with intellectual disability and/or autism spectrum disorder, because of a variety of biological and psychosocial reasons. AIMS: This study aimed to estimate if...
Autores principales: | Rauf, Bushra, Sheikh, Hafsa, Majid, Hassan, Roy, Ashok, Pathania, Rani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058854/ https://www.ncbi.nlm.nih.gov/pubmed/33736746 http://dx.doi.org/10.1192/bjo.2021.26 |
Ejemplares similares
-
UK psychiatrists’ experience of withdrawal of antipsychotics prescribed for challenging behaviours in adults with intellectual disabilities and/or autism
por: Deb, Shoumitro, et al.
Publicado: (2020) -
Prescribing antipsychotic medication for adults with intellectual disability: shared responsibilities between mental health services and primary care
por: Paton, Carol, et al.
Publicado: (2022) -
Priority concerns for people with intellectual and developmental disabilities during the COVID-19 pandemic
por: Tromans, Sam, et al.
Publicado: (2020) -
Withdrawing Antipsychotics for Challenging Behaviours in Adults with Intellectual Disabilities: Experiences and Views of Prescribers
por: de Kuijper, Gerda, et al.
Publicado: (2022) -
COVID-19 pandemic impact on psychotropic prescribing for adults with intellectual disability: an observational study in English specialist community services
por: Naqvi, Danial, et al.
Publicado: (2021)